Try our beta test site
927 studies found for:    pharmacogenomics OR pharmacogenetics
Show Display Options
Rank Status Study
21 Recruiting Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients
Condition: Atrial Fibrillation
Interventions: Genetic: Pharmacogenetic anticoagulation;   Drug: Traditional anticoagulation
22 Recruiting The Pharmacogenetics of Optimal Warfarin Therapy in Chinese Patients After Heart Valve Replacement.
Conditions: Heart Valve Disease;   Older Than 18-years-old;   Without Any Liver or Kidney Diseases
Intervention: Genetic: CYP2C9;VKORC1
23 Completed
Has Results
Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin
Condition: Thromboembolism
Interventions: Genetic: IWPC adapted genotype-guided dosing algorithm for warfarin;   Genetic: Modified IWPC genetic-guided warfarin dosing algorithm;   Other: Standard of care treatment
24 Completed Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System Reinforced With Patient Specific Pharmacogenetic Data for Minimizing Severe Drug-Drug Interactions
Condition: Healthcare
Intervention: Other: DDI+ System and Pharmacogenetic Data
25 Completed Pharmacogenetic Testing in Primary Care
Condition: Pharmacogenetic Testing
Intervention:
26 Completed Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia
Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Intervention:
27 Recruiting Pharmacogenomics of New Antiretrovirals
Condition: HIV
Intervention:
28 Completed
Has Results
Clopidogrel Pharmacogenomics Project
Condition: Disease Susceptibility
Interventions: Drug: clopidogrel 75 mg;   Drug: Clopidogrel 150 mg
29 Withdrawn Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: Cisplatin;   Drug: Cetuximab
30 Enrolling by invitation Integrating Pharmacogenetics In Clinical Care
Condition: Cardiovascular Disease
Intervention: Genetic: SLCO1B1 Genotype
31 Unknown  Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
Condition: Bipolar Affective Disorder
Intervention: Drug: Mood stabilizer treatment
32 Unknown  Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention:
33 Completed
Has Results
Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin Therapy
Condition: Blood Clotting
Interventions: Genetic: warfarin pharmacogenetic dosing;   Drug: Warfarin
34 Completed Pharmacogenetic Dosage Algorithm for Acenocoumarol
Conditions: Atrial Fibrillation;   Venous Thromboses;   Cardiac Valve Disease
Intervention: Genetic: Acenocoumarol
35 Unknown  Pharmacogenetics to Predict Drug Interactions in Kidney Transplant Recipients
Condition: Kidney Transplantation
Interventions: Drug: Tacrolimus + Ketoconazole;   Drug: Tacrolimus alone
36 Recruiting Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose
Condition: Indications for Warfarin Therapy
Intervention: Drug: Warfarin Sodium
37 Recruiting Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate
Condition: Pharmacogenetic Study
Intervention: Drug: Abiraterone Acetate
38 Completed Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)
Condition: HIV Infections
Intervention:
39 Recruiting Predict Antidepressant Responsiveness Using Pharmacogenomics
Conditions: Depression;   Depressive Symptoms
Interventions: Drug: SSRI treated group;   Drug: non-SSRI treated group
40 Terminated
Has Results
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Conditions: Cardiovascular Diseases;   Acute Coronary Syndrome
Interventions: Drug: clopidogrel;   Drug: prasugrel

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.